734-936-8000 - Service Desk | Request Support

COVID-19 Update for Anesthesiology Providers

To begin this activity, click Enroll. Once logged in, learners can access educational content, assessments, and evaluations. Learners who successfully complete the activity will be able to print a certificate.

Step Status
Educational Materials
Release Date: Fri, 4/3/20
Termination Date: Fri, 7/31/20
Credits: 0.5

COVID-19 Update for Anesthesiology Providers

Presenter: Daniel J. Clauw, MD

There are no relevant financial relationships to disclose for this activity.
Educational Objectives: An overview of current evidence regarding COVID-19 pathophysiology, transmission, mortality, and treatments.
Target Audience: This activity is appropriate for: Physicians, Physician Assistants, Nurse Practitioners, Nurses and Other Healthcare Professionals, in the fields of Anesthesiology.
Accreditation Information:

The University of Michigan Medical School is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The University of Michigan Medical School designates this enduring material for a maximum of .5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Release Date: 4/3/2020
Termination Date: 7/31/2020

Maintenance of Certification in Anesthesiology™ program and MOCA® are registered trademarks of The American Board of Anesthesiology®. This activity contributes to the CME component of the American Board of Anesthesiology's redesigned Maintenance of Certification in AnesthesiologyTM (MOCA®) program, known as MOCA 2.0®. Please consult the ABA website, www.theABA.org, for a list of all MOCA 2.0 requirements."
Additional Info:
  1. Gane SB, Kelly C, Hopkins C. Isolated sudden onset anosmia in COVID-19 infection. A novel syndrome? Rhinology 2020.
  2. Baden LR, Rubin EJ. Covid-19 - The Search for Effective Therapy. The New England Journal of Medicine 2020.
  3. Zhang X. Epidemiology of Covid-19. The New England journal of medicine 2020;382.
  4. Cao B, Wang Y, Wen D, et al. A Trial of Lopinavir-Ritonavir in Adults Hospitalized with Severe Covid-19. The New England Journal of Medicine 2020.
  5. Onder G, Rezza G, Brusaferro S. Case-Fatality Rate and Characteristics of Patients Dying in Relation to COVID-19 in Italy. JAMA 2020.
  6. Lan L, Xu D, Ye G, et al. Positive RT-PCR Test Results in Patients Recovered From COVID-19. JAMA 2020.
  7. Bai Y, Yao L, Wei T, et al. Presumed Asymptomatic Carrier Transmission of COVID-19. JAMA 2020.
  8. Patel AB, Verma A. COVID-19 and Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers: What Is the Evidence? JAMA 2020.
  9. Bourouiba L. Turbulent Gas Clouds and Respiratory Pathogen Emiss
Categories: COVID

Credits available:

ABA MOC Part II: 0.50
AMA PRA Category 1: 0.50
Participation: 0.50